Go to deals
TMT

LeadDesk Oyj has raised US$7m in the course of its IPO on Nasdaq First North Finland

LeadDesk Oyj has completed an IPO on NASDAQ First North Finland during which the company raised US$7 million. The shares of the company started trading on 15 February 2019.

LeadDesk Oyj provides cloud-based solutions for high-volume sales and customer service. The offering includes LeadDesk contact centre cloud solution as a self-provisioning software-as-a-service platform and LeadCloud services for high quality leads and improved hit-rate in direct marketing.

Oaklins' team in Finland acted as financial advisor to LeadDesk Oyj in the course of its IPO on NASDAQ First North Finland. LeadDesk Oyj has appointed the Finnish team as its Certified Advisor.

Service
Funding, debt advisory & ECM
Parties
“We are delighted by the interest investors have shown in our IPO. LeadDesk is a high-growth leader in its field in the Nordics and Central Europe. Our goal is to be Europe’s largest SaaS company serving the needs of high-volume sales and customer service. The IPO places us in a great position to execute our growth strategy. We would like to thank Oaklins' team in Finland for the great work they have done to support our IPO. They showed dedication and expertise throughout the whole process and ensured that we achieved the desired result. We look forward to working together with Oaklins in the future.”

Olli Nokso-Koivisto

CEO, LeadDesk Oyj

Talk to the deal team

 Marcus  Blomqvist

Marcus Blomqvist

Partner

Helsinki, Finland
Oaklins Merasco

Related deals

RGI acquires 100% of the shares in Flexperto GmbH
TMT

RGI acquires 100% of the shares in Flexperto GmbH

The shareholders and founders of Flexperto GmbH have sold the company to RGI S.p.A. The founders remain as managing directors and have already reinvested in the parent company. Whereas Flexperto’s sales activities were solely focused on the German-speaking financial services market, with the sale to RGI, both companies seek to expand these activities to other markets and industries.

Learn more
Shield Therapeutics has raised funds
Healthcare

Shield Therapeutics has raised funds

Shield Therapeutics Plc has completed a placing, subscription and open offer. The primary use of the funds is to launch Accrufer® in the USA.

Learn more
Jersey Oil & Gas has completed a private placement of new shares
Energy

Jersey Oil & Gas has completed a private placement of new shares

Jersey Oil & Gas Plc has raised funds to support a new development project.

Learn more